Cite Filings / KROS / 0001628280-24-000192

Feed Companies Filings Check

Sign in

424B5

Prospectus

Keros Therapeutics, Inc. Filed 2024-01-03 Acc 0001628280-24-000192

Documents 1

424B5 Prospectus , keros424b5january2024.htm

Around this filing

2024-01-08 4 Chief Financial Officer sold 40,000 shares at $45.29 ($1,811,600)
2024-01-04 144 Sale of Securities
2024-01-04 8-K Other events
2024-01-04 424B5 Prospectus
2024-01-03 8-K Regulation FD disclosure · Other events
2024-01-03 424B5 Prospectus
2022-12-12 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading keros424b5january2024.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…